Galvanize Therapeutics Secures $100 Million for Innovative Cancer and Lung Disease Treatments Galvanize Therapeutics has raised $100 million in Series C funding, aiming to revolutionize treatments for cancer and chronic lung disease with its unique PEF technology.

Galvanize Therapeutics Secures $100 Million for Innovative Cancer and Lung Disease Treatments #United_States #Redwood_City #Galvanize_Therapeutics #Sofinnova_Partners #PEF_Technology